The role of HER2 status and targeted therapy with trastuzumab in advanced endometrial cancer, emphasizing the need for effective management of cardiac toxicities and comorbidities.
Engelstad Foundation Donates $1 5 Million Toward Wave Neuroscience s Phase Two Trial for PTSD and TBI Treatment tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
The Market for Cannabis Companies Continues to Grow and See Rising Sales Numbers as More and More States in the U.S. Legalize Marijuana and for Some Companies, Like Curaleaf, 2021 May Be Better Financially Than Anyone Expected Based on its Most Recent Quarterly Report
Curaleaf (CSE:CURA) (OTCQX:CURLF), showed strong first-quarter earnings. These earnings have put them on track to deliver well-above-consensus numbers for the year. They also beat Curaleaf’s own guidance for full-year revenue ($1.2 billion) and are now expecting $1.3 billion. Analysts believe Curaleaf’s impressive performance is due to a number of factors, one of the most significant being that Curaleaf is an all-encompassing company. Curaleaf has a balance and depth within U.S. markets; they are prepared for federal legalization, and they have a strong balance sheet.